Inflammatory bowel disease (IBD) has a well-known increased risk of colorectal cancer (CRC).1 Therefore guidelines recommend meticulous endoscopic surveillance , aiming for a reduction in CRC-related death by detecting and treating lesions in a premalignant state. All guidelines currently suggest the use of chromo-endoscopy with targeted biopsies (ESGE and ECCO)2,3 or with random biopsies every 10 centimeter (SCENIC, ESGE and ECCO).2-4 Although several quality criteria have been defined for colorectal cancer screening programs, and for colonoscopy specifically 2 , there is still a need for validated quality indicators that should be met when performing an IBD surveillance endoscopy.

中文翻译：

---

押注质量指标以改善 IBD 监测结果：全押还是选择一个？

众所周知，炎症性肠病 (IBD) 会增加结直肠癌 (CRC) 的风险。1 因此，指南建议进行细致的内镜监测，旨在通过检测和治疗癌前病变来减少 CRC 相关死亡。目前所有的指南都建议使用色素内窥镜进行靶向活检（ESGE 和 ECCO）2,3 或每 10 厘米随机活检（SCENIC、ESGE 和 ECCO）2-4。尽管已经定义了几个用于结肠直肠癌筛查的质量标准计划，特别是结肠镜检查 2 ，仍然需要经过验证的质量指标，在执行 IBD 监测内窥镜检查时应满足这些指标。